Profile
J.
Michael French served as President & Chief Executive Officer at MDRNA, Inc. from 2008 to 2010.
He was also Chairman, President & Chief Executive Officer at Adhera Therapeutics, Inc. from 2012 to 2016.
Prior to that, he was Senior Vice President-Corporate Development at Sirna Therapeutics, Inc. from 2005 to 2006 and Chief Business Officer & SVP-Business Development at Entelos, Inc. from 2000 to 2005.
In 2007, he briefly served as President at Rosetta Genomics Ltd.
French received his undergraduate degree from the US Military Academy and his graduate degree from Georgetown University.
Former positions of J. Michael French
| Companies | Position | End |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Chief Executive Officer | 2016-06-09 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | President | 2010-07-21 |
| ROSETTA GENOMICS LTD. | President | 2007-07-31 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2006-09-30 |
Entelos, Inc.
 Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 2004-12-31 |
Training of J. Michael French
| Georgetown University | Graduate Degree |
| US Military Academy | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ROSETTA GENOMICS LTD. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
- Stock Market
- Insiders
- J. Michael French
